{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:24:56Z","timestamp":1792452296083,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T00:00:00Z","timestamp":1667865600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br J Cancer"],"published-print":{"date-parts":[[2023,1,26]]},"DOI":"10.1038\/s41416-022-02037-5","type":"journal-article","created":{"date-parts":[[2022,11,8]],"date-time":"2022-11-08T12:13:22Z","timestamp":1667909602000},"page":"42-47","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Age alone is not a barrier to efficacy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: analysis of 1138 patients from the UK and Ireland Colorectal Peritoneal Metastases Registry"],"prefix":"10.1038","volume":"128","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0757-6411","authenticated-orcid":false,"given":"Michael E.","family":"Kelly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niall J.","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0796-633X","authenticated-orcid":false,"given":"Jarlath C.","family":"Bolger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Polignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haney","family":"Youssef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Renehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Malcomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sue","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Cecil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00fcrgen","family":"Mulsow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faheez","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"UK & Ireland Colorectal Peritoneal Metastases Registry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronan","family":"Cahill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faraz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeev","family":"Dayal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connor","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexios","family":"Tzivanakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,11,8]]},"reference":[{"key":"2037_CR1","doi-asserted-by":"crossref","unstructured":"Dietz MV, van Kooten JP, Said I, Brandt-Kerkhof ARM, Verhoef C, Bremers AJA, et al. Survival outcomes after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy in patients with synchronous versus metachronous onset of peritoneal metastases of colorectal carcinoma. Ann Surg Oncol. 2022; 29:6566\u201376.","DOI":"10.1245\/s10434-022-11805-9"},{"key":"2037_CR2","doi-asserted-by":"publisher","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","volume":"17","author":"J Franko","year":"2016","unstructured":"Franko J, Shi Q, Meyers JP, Maughan TS, Adams RA, Seymour MT, et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol. 2016;17:1709\u201319.","journal-title":"Lancet Oncol"},{"key":"2037_CR3","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1002\/bjs5.50179","volume":"3","author":"S Hallam","year":"2019","unstructured":"Hallam S, Tyler R, Price M, Beggs A, Youssef H. Meta-analysis of prognostic factors for patients with colorectal peritoneal metastasis undergoing cytoreductive surgery and heated intraperitoneal chemotherapy. BJS Open. 2019;3:585\u201394.","journal-title":"BJS Open"},{"key":"2037_CR4","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1097\/XCS.0000000000000091","volume":"234","author":"ME Lundy","year":"2022","unstructured":"Lundy ME, Moaven O, Perry KC, Mangieri CW, Valenzuela CD, Russell GB, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for management of colorectal cancer with peritoneal dissemination: 30 years of experience at a single institution. J Am Coll Surg. 2022;234:546\u201356.","journal-title":"J Am Coll Surg"},{"key":"2037_CR5","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/jso.23728","volume":"110","author":"A Prada-Villaverde","year":"2014","unstructured":"Prada-Villaverde A, Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, et al. The American Society of Peritoneal Surface Malignancies evaluation of HIPEC with Mitomycin C versus Oxaliplatin in 539 patients with colon cancer undergoing a complete cytoreductive surgery. J Surg Oncol. 2014;110:779\u201385.","journal-title":"J Surg Oncol"},{"key":"2037_CR6","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1200\/JCO.2008.19.7160","volume":"27","author":"D Elias","year":"2009","unstructured":"Elias D, Lefevre JH, Chevalier J, Brouquet A, Marchal F, Classe JM, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681\u20135.","journal-title":"J Clin Oncol"},{"key":"2037_CR7","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.ejso.2010.05.007","volume":"36","author":"L Maggiori","year":"2010","unstructured":"Maggiori L, Elias D. Curative treatment of colorectal peritoneal carcinomatosis: current status and future trends. Eur J Surg Oncol. 2010;36:599\u2013603.","journal-title":"Eur J Surg Oncol"},{"key":"2037_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.yasu.2021.05.012","volume":"55","author":"CH Davis","year":"2021","unstructured":"Davis CH, Alexander HR Jr. What is the Current role of hyperthermic intraperitoneal chemotherapy in colorectal cancer? Adv Surg. 2021;55:159\u201374.","journal-title":"Adv Surg"},{"key":"2037_CR9","doi-asserted-by":"publisher","first-page":"903","DOI":"10.4251\/wjgo.v12.i8.903","volume":"12","author":"J Spiegelberg","year":"2020","unstructured":"Spiegelberg J, Neeff H, Holzner P, Runkel M, Fichtner-Feigl S, Glatz T. Comparison of hyperthermic intraperitoneal chemotherapy regimens for treatment of peritoneal-metastasized colorectal cancer. World J Gastrointest Oncol. 2020;12:903\u201317.","journal-title":"World J Gastrointest Oncol"},{"key":"2037_CR10","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/S1470-2045(20)30599-4","volume":"22","author":"F Quenet","year":"2021","unstructured":"Quenet F, Elias D, Roca L, Goere D, Ghouti L, Pocard M, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021;22:256\u201366.","journal-title":"Lancet Oncol"},{"key":"2037_CR11","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/1878-0261.12417","volume":"13","author":"G Mauri","year":"2019","unstructured":"Mauri G, Sartore-Bianchi A, Russo AG, Marsoni S, Bardelli A, Siena S. Early-onset colorectal cancer in young individuals. Mol Oncol. 2019;13:109\u201331.","journal-title":"Mol Oncol"},{"key":"2037_CR12","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1245\/s10434-017-6313-5","volume":"25","author":"J Gagniere","year":"2018","unstructured":"Gagniere J, Veziant J, Pereira B, Pezet D, Le Roy B, Slim K. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the elderly: is it reasonable? A meta-analysis. Ann Surg Oncol. 2018;25:709\u201319.","journal-title":"Ann Surg Oncol"},{"key":"2037_CR13","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1007\/s13304-020-00966-5","volume":"73","author":"W Ezzedine","year":"2021","unstructured":"Ezzedine W, Mege D, Aubert M, Duclos J, Le Huu Nho R, et al. Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy for resectable peritoneal metastases is feasible in elderly patients. Updates Surg. 2021;73:719\u201330.","journal-title":"Updates Surg"},{"key":"2037_CR14","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1245\/s10434-020-09415-4","volume":"28","author":"K Zambrano-Vera","year":"2021","unstructured":"Zambrano-Vera K, Sardi A, Lopez-Ramirez F, Sittig M, Munoz-Zuluaga C, Nieroda C, et al. Outcomes for elderly ovarian cancer patients treated with cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS\/HIPEC). Ann Surg Oncol. 2021;28:4655\u201366.","journal-title":"Ann Surg Oncol"},{"key":"2037_CR15","first-page":"5330","volume":"25","author":"J Tao","year":"2021","unstructured":"Tao J, Ji PT, Shen JJ, Lu Y. Survival and complications of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in elderly patients: a systematic review and meta-analysis. Eur Rev Med Pharm Sci. 2021;25:5330\u201348.","journal-title":"Eur Rev Med Pharm Sci"},{"key":"2037_CR16","doi-asserted-by":"publisher","first-page":"2888","DOI":"10.1016\/j.ejso.2021.05.023","volume":"47","author":"VCJ van de Vlasakker","year":"2021","unstructured":"van de Vlasakker VCJ, Lurvink RJ, Cashin PH, Ceelen W, Deraco M, Goere D, et al. The impact of PRODIGE 7 on the current worldwide practice of CRS-HIPEC for colorectal peritoneal metastases: a web-based survey and 2021 statement by Peritoneal Surface Oncology Group International (PSOGI). Eur J Surg Oncol. 2021;47:2888\u201392.","journal-title":"Eur J Surg Oncol"},{"key":"2037_CR17","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1097\/DCR.0b013e3182a586e7","volume":"57","author":"SR Steele","year":"2014","unstructured":"Steele SR, Park GE, Johnson EK, Martin MJ, Stojadinovic A, Maykel JA, et al. The impact of age on colorectal cancer incidence, treatment, and outcomes in an equal-access health care system. Dis Colon Rectum. 2014;57:303\u201310.","journal-title":"Dis Colon Rectum"},{"key":"2037_CR18","doi-asserted-by":"publisher","first-page":"e3641","DOI":"10.1097\/MD.0000000000003641","volume":"95","author":"TJ Kim","year":"2016","unstructured":"Kim TJ, Kim ER, Hong SN, Chang DK, Kim YH. Long-term outcome and prognostic factors of sporadic colorectal cancer in young patients: a large institutional-based retrospective study. Med (Baltim). 2016;95:e3641.","journal-title":"Med (Baltim)"},{"key":"2037_CR19","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1177\/000313481708300630","volume":"83","author":"NM Hinkle","year":"2017","unstructured":"Hinkle NM, Botta V, Sharpe JP, Dickson P, Deneve J, Munene G. The impact of early recurrence on quality of life after cytoreduction with HIPEC. Am Surg. 2017;83:633\u20139.","journal-title":"Am Surg"},{"key":"2037_CR20","doi-asserted-by":"publisher","first-page":"2958","DOI":"10.1245\/s10434-015-4387-5","volume":"22","author":"D Goere","year":"2015","unstructured":"Goere D, Souadka A, Faron M, Cloutier AS, Viana B, Honore C, et al. Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study. Ann Surg Oncol. 2015;22:2958\u201364.","journal-title":"Ann Surg Oncol"},{"issue":"Suppl","key":"2037_CR21","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1007\/s002800051093","volume":"43","author":"PH Sugarbaker","year":"1999","unstructured":"Sugarbaker PH. Successful management of microscopic residual disease in large bowel cancer. Cancer Chemother Pharm. 1999;43(Suppl):S15\u201325.","journal-title":"Cancer Chemother Pharm"},{"key":"2037_CR22","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1016\/j.ejso.2013.09.030","volume":"39","author":"N Bakrin","year":"2013","unstructured":"Bakrin N, Bereder JM, Decullier E, Classe JM, Msika S, Lorimier G, et al. Peritoneal carcinomatosis treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients. Eur J Surg Oncol. 2013;39:1435\u201343.","journal-title":"Eur J Surg Oncol"},{"key":"2037_CR23","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1200\/JCO.2011.39.7166","volume":"30","author":"TC Chua","year":"2012","unstructured":"Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol. 2012;30:2449\u201356.","journal-title":"J Clin Oncol"},{"key":"2037_CR24","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1245\/s10434-010-1039-7","volume":"17","author":"O Glehen","year":"2010","unstructured":"Glehen O, Gilly FN, Arvieux C, Cotte E, Boutitie F, Mansvelt B, et al. Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy. Ann Surg Oncol. 2010;17:2370\u20137.","journal-title":"Ann Surg Oncol"},{"key":"2037_CR25","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1245\/ASO.2004.08.014","volume":"11","author":"VJ Verwaal","year":"2004","unstructured":"Verwaal VJ, Boot H, Aleman BM, van Tinteren H, Zoetmulder FA. Recurrences after peritoneal carcinomatosis of colorectal origin treated by cytoreduction and hyperthermic intraperitoneal chemotherapy: location, treatment, and outcome. Ann Surg Oncol. 2004;11:375\u20139.","journal-title":"Ann Surg Oncol"},{"key":"2037_CR26","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1245\/s10434-007-9410-z","volume":"14","author":"L Bijelic","year":"2007","unstructured":"Bijelic L, Yan TD, Sugarbaker PH. Failure analysis of recurrent disease following complete cytoreduction and perioperative intraperitoneal chemotherapy in patients with peritoneal carcinomatosis from colorectal cancer. Ann Surg Oncol. 2007;14:2281\u20138.","journal-title":"Ann Surg Oncol"},{"key":"2037_CR27","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1016\/j.ejso.2015.05.018","volume":"41","author":"TR van Oudheusden","year":"2015","unstructured":"van Oudheusden TR, Nienhuijs SW, Luyer MD, Nieuwenhuijzen GA, Lemmens VE, Rutten HJ, et al. Incidence and treatment of recurrent disease after cytoreductive surgery and intraperitoneal chemotherapy for peritoneally metastasized colorectal cancer: a systematic review. Eur J Surg Oncol. 2015;41:1269\u201377.","journal-title":"Eur J Surg Oncol"},{"key":"2037_CR28","doi-asserted-by":"publisher","first-page":"3973","DOI":"10.1245\/s10434-020-08379-9","volume":"27","author":"M Leimkuhler","year":"2020","unstructured":"Leimkuhler M, Hentzen J, Hemmer PHJ, Been LB, van Ginkel RJ, Kruijff S, et al. Systematic review of factors affecting quality of life after cytoreductive surgery with hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2020;27:3973\u201383.","journal-title":"Ann Surg Oncol"},{"key":"2037_CR29","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.gpb.2016.12.004","volume":"15","author":"X Han","year":"2017","unstructured":"Han X, Wang J, Sun Y. Circulating tumor DNA as biomarkers for cancer detection. Genomics Proteom Bioinforma. 2017;15:59\u201372.","journal-title":"Genomics Proteom Bioinforma"},{"key":"2037_CR30","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1002\/ijc.33217","volume":"148","author":"I Heidrich","year":"2021","unstructured":"Heidrich I, Ackar L, Mossahebi Mohammadi P, Pantel K. Liquid biopsies: potential and challenges. Int J Cancer. 2021;148:528\u201345.","journal-title":"Int J Cancer"},{"key":"2037_CR31","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-84816-3","volume":"11","author":"A Delli Pizzi","year":"2021","unstructured":"Delli Pizzi A, Chiarelli AM, Chiacchiaretta P, d\u2019Annibale M, Croce P, Rosa C, et al. MRI-based clinical-radiomics model predicts tumor response before treatment in locally advanced rectal cancer. Sci Rep. 2021;11:5379.","journal-title":"Sci Rep"},{"key":"2037_CR32","doi-asserted-by":"crossref","unstructured":"Boland PA, Kelly ME. Advanced colorectal cancer: redefining the outcome paradigm; balancing cure with quality of life. Colorectal Dis. 2021;24:155\u20136.","DOI":"10.1111\/codi.15950"},{"key":"2037_CR33","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/codi.13238","volume":"18","author":"Y Ribas","year":"2016","unstructured":"Ribas Y, Hotouras A, Wexner SD, D\u2019Hoore A. Shared decision-making and informed consent process in rectal cancer treatment: weighing up oncological and functional outcomes. Colorectal Dis. 2016;18:9\u201312.","journal-title":"Colorectal Dis"},{"key":"2037_CR34","doi-asserted-by":"publisher","first-page":"9098","DOI":"10.1245\/s10434-021-10193-w","volume":"28","author":"A Bhatt","year":"2021","unstructured":"Bhatt A, de Hingh I, Van Der Speeten K, Hubner M, Deraco M, Bakrin N, et al. HIPEC methodology and regimens: the need for an expert consensus. Ann Surg Oncol. 2021;28:9098\u2013113.","journal-title":"Ann Surg Oncol"},{"key":"2037_CR35","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1245\/s10434-021-10905-2","volume":"28","author":"T Jastrzebski","year":"2021","unstructured":"Jastrzebski T, Goscinski M. HIPEC in complementary treatment to cytoreductive procedures: an unexplained issue After the PRODIGE 7 Trial. Ann Surg Oncol. 2021;28:803\u20135.","journal-title":"Ann Surg Oncol"},{"key":"2037_CR36","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.21037\/jgo-2020-15","volume":"12","author":"PH Sugarbaker","year":"2021","unstructured":"Sugarbaker PH, Van der Speeten K. The PRODIGE 7 randomized trial has 4 design flaws and 4 pharmacologic flaws and cannot be used to discredit other HIPEC regimens. J Gastrointest Oncol. 2021;12:S129\u2013S30.","journal-title":"J Gastrointest Oncol"}],"container-title":["British Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-02037-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-02037-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-02037-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T22:03:54Z","timestamp":1673215434000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41416-022-02037-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,8]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1,26]]}},"alternative-id":["2037"],"URL":"https:\/\/doi.org\/10.1038\/s41416-022-02037-5","relation":{},"ISSN":["0007-0920","1532-1827"],"issn-type":[{"value":"0007-0920","type":"print"},{"value":"1532-1827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,8]]},"assertion":[{"value":"15 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}